| NCT06072001 | Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis | Apurano Pharmaceuticals GmbH | Parallel Assignment | - Age ≥ 18 yrs
- Level C1-S5
AIS - All
- NOT have a history of addiction.
- understand German.
| Recruiting | 558 | Phase 3 | Drug | Pain | - Brief Pain Inventory (BPI)
- Depression Anxiety Stress Scale-21 (DASS-21)
- Neuropathoc Pain Symptom Inventory (NPSI)
- Pain Numeric Rating Scale (NRS)
| 52 weeks | 02 November 2023 | 10 October 2023 | 1 | |
| NCT05982171 | Transcutaneous Spinal Cord Stimulation to Promote Walking Recovery After Spinal Cord Injury | Craig Hospital | | - Age ≥ 18 yrs
- Level C4-T10
AIS B, C, D- ≤ 12 months
- must be between 5'0" and 6'4" in height
- NOT have a cauda equina injury
- NOT have cardiac or respiratory issues
| Active | 30 | NA | Technology | Standing/walking/mobility | - 10 Meter Walking Test (10 MWT)
- 6-Minute Walk Test (6MWT)
- Neurogenic Bladder Symptom Score
- Neurogenic Bowel Dysfunction Score (NBD or NBDS)
- Penn Spasm Frequency Scale (PSFS)
- Walking Index for Spinal Cord Injury (WISCI) and WISCI II
| 4 weeks after the last session | 15 November 2023 | 08 August 2023 | 1 | |
| NCT05920174 | Clinical Trial to Evaluate the Safety and Efficacy of an Implantable Neural Acquisitor & Stimulator System in Patients With Motor Disability | Neuracle Medical Technology(Shanghai) Co.,Ltd. | Single Group Assignment | - Age 18 - 80 yrs
- Level C1-C8
AIS A, B, C, D- ≥ 1 years
| Recruiting soon | 9 | Not Applicable | Technology | General health | | 12 months | 01 July 2023 | 27 June 2023 | 3 | |
| NCT05870189 | Remotely Delivered Cognitive Multisensory Rehabilitation for Sensory and Motor Recovery After Spinal Cord Injury | University of Minnesota | | - Age 18 - 75 yrs
- Level C1-S5
AIS A, B, C, D- ≥ 3 months
| Ended | 19 | PHASE2 | Rehabilitation | Standing/walking/mobility | - American Spinal Injury Association Impairment Scale (AIS): International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI)
- Neuromuscular Recovery Scale
| 12 weeks | 01 June 2023 | 23 May 2023 | 1 | |
| NCT06011876 | BioFLO for Respiratory Recovery in SCI | University of Florida | | - Age 18 - 70 yrs
- Level C3-T12
AIS B, C, D- ≥ 1 years
- have an SCI due to non-progressive etiology
- NOT have a cardiac pacemaker
- NOT have metal implants in the skull
- NOT have a diagnosis of an additional neurologic condition
- have 20% impairment in maximal inspiratory or expiratory pressure generation, relative to normative values
| Recruiting | 62 | NA | Drug | General health | | 7 days | 21 December 2023 | 25 August 2023 | 1 | |
| NCT06066918 | Prophylactic Pregabalin Treatment Following Spinal Cord Injury | Loewenstein Hospital | | - Age 18 - 70 yrs
- Level C4-S5
AIS - ≤ 2 months
- have SCI below C3
| Recruiting | 50 | NA | Drug | Pain | - Depression Anxiety Stress Scale-21 (DASS-21)
- Pain Visual Analog Scale (VAS)
| 1 year | 13 July 2021 | 04 October 2023 | 2 | |
